Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Lewis: Ab Specificity & Fc-Mediated Protection |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2012-04-03 |
| Study Made Public: | 2014-10-22 |
Title
Specificity of anti-gp41 monoclonal antibodies that mediate ADCC
Description
CAVD 360 is an immunogenicity study to define the epitopes recognized by a panel of anti-gp41 monoclonal antibodies that mediate ADCC.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.